Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityOther Accumulated ExpensesPayablesPrepaid AssetsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Marker Therapeutics (MRKR) Prepaid Assets (2016 - 2025)

Historic Prepaid Assets for Marker Therapeutics (MRKR) over the last 11 years, with Q1 2025 value amounting to $841293.0.

  • Marker Therapeutics' Prepaid Assets fell 825.68% to $841293.0 in Q1 2025 from the same period last year, while for Mar 2025 it was $841293.0, marking a year-over-year decrease of 825.68%. This contributed to the annual value of $483717.0 for FY2024, which is 5104.7% down from last year.
  • Marker Therapeutics' Prepaid Assets amounted to $841293.0 in Q1 2025, which was down 825.68% from $483717.0 recorded in Q4 2024.
  • Marker Therapeutics' 5-year Prepaid Assets high stood at $2.8 million for Q2 2022, and its period low was $483717.0 during Q4 2024.
  • Moreover, its 5-year median value for Prepaid Assets was $2.0 million (2021), whereas its average is $1.9 million.
  • Per our database at Business Quant, Marker Therapeutics' Prepaid Assets skyrocketed by 2073.5% in 2021 and then plummeted by 6224.35% in 2024.
  • Marker Therapeutics' Prepaid Assets (Quarter) stood at $2.5 million in 2021, then dropped by 25.57% to $1.8 million in 2022, then crashed by 46.57% to $988126.0 in 2023, then plummeted by 51.05% to $483717.0 in 2024, then skyrocketed by 73.92% to $841293.0 in 2025.
  • Its Prepaid Assets was $841293.0 in Q1 2025, compared to $483717.0 in Q4 2024 and $1.2 million in Q3 2024.